Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
1.220
0.00 (0.00%)
May 13, 2025, 3:55 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Novel Medicines for Central Nervous System Disorders
3.13M
Log In
Log In
Log In
Log In
Novel Medicines for Central Nervous System Disorders Growth
-847.61%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
United States
3.13M
Log In
Log In
Log In
Log In
United States Growth
-847.61%
Log In
Log In
Log In
Log In